Mexico-based healthcare company Grupo Vitalmex invests $2m in US-based cell technology company Bioheart.
Mexico-based healthcare company Grupo Vitalmex has invested $2m in US-based cell technology company Bioheart.
Bioheart was founded in 2009.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
